Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 41.49 Million USD | -70.33% |
| 2022 | 139.82 Million USD | 5.05% |
| 2021 | 133.1 Million USD | 75.67% |
| 2020 | 75.77 Million USD | -22.81% |
| 2019 | 98.16 Million USD | 22.12% |
| 2018 | 80.38 Million USD | -6.65% |
| 2017 | 86.11 Million USD | 26.38% |
| 2016 | 68.13 Million USD | 25.52% |
| 2015 | 54.28 Million USD | 25.15% |
| 2014 | 43.37 Million USD | 3.56% |
| 2013 | 41.88 Million USD | 0.82% |
| 2012 | 41.54 Million USD | 21.07% |
| 2011 | 34.31 Million USD | 13.56% |
| 2010 | 30.21 Million USD | -5.35% |
| 2009 | 31.92 Million USD | -37.43% |
| 2008 | 51.02 Million USD | -23.53% |
| 2007 | 66.72 Million USD | -5.8% |
| 2006 | 70.83 Million USD | 26.88% |
| 2005 | 55.82 Million USD | 47.1% |
| 2004 | 37.95 Million USD | 41.77% |
| 2003 | 26.77 Million USD | 46.0% |
| 2002 | 18.33 Million USD | 48.03% |
| 2001 | 12.38 Million USD | 100.89% |
| 2000 | 6.16 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 11.02 Million USD | 146.22% |
| 2024 Q2 | 6.26 Million USD | -43.18% |
| 2023 FY | 41.49 Million USD | -70.33% |
| 2023 Q3 | 3.44 Million USD | -87.73% |
| 2023 Q1 | 24.92 Million USD | -35.67% |
| 2023 Q2 | 28.05 Million USD | 12.54% |
| 2023 Q4 | 4.47 Million USD | 30.17% |
| 2022 Q4 | 38.74 Million USD | 13.14% |
| 2022 FY | 139.82 Million USD | 5.05% |
| 2022 Q1 | 31.78 Million USD | -16.74% |
| 2022 Q2 | 35.04 Million USD | 10.24% |
| 2022 Q3 | 34.24 Million USD | -2.27% |
| 2021 Q1 | 27.71 Million USD | -1.27% |
| 2021 FY | 133.1 Million USD | 75.67% |
| 2021 Q3 | 33.42 Million USD | -1.08% |
| 2021 Q4 | 38.18 Million USD | 14.23% |
| 2021 Q2 | 33.78 Million USD | 21.94% |
| 2020 FY | 75.77 Million USD | -22.81% |
| 2020 Q1 | 14.33 Million USD | -50.2% |
| 2020 Q2 | 11.62 Million USD | -18.92% |
| 2020 Q4 | 28.06 Million USD | 29.07% |
| 2020 Q3 | 21.74 Million USD | 87.07% |
| 2019 Q2 | 25.83 Million USD | 49.23% |
| 2019 Q1 | 17.3 Million USD | -7.86% |
| 2019 Q4 | 28.79 Million USD | 9.75% |
| 2019 Q3 | 26.23 Million USD | 1.56% |
| 2019 FY | 98.16 Million USD | 22.12% |
| 2018 Q3 | 21.88 Million USD | -2.2% |
| 2018 Q1 | 17.33 Million USD | -36.58% |
| 2018 Q2 | 22.37 Million USD | 29.09% |
| 2018 FY | 80.38 Million USD | -6.65% |
| 2018 Q4 | 18.78 Million USD | -14.16% |
| 2017 Q2 | 21.04 Million USD | 35.6% |
| 2017 Q4 | 27.33 Million USD | 23.07% |
| 2017 Q3 | 22.21 Million USD | 5.53% |
| 2017 FY | 86.11 Million USD | 26.38% |
| 2017 Q1 | 15.52 Million USD | -29.17% |
| 2016 Q1 | 12.47 Million USD | -30.3% |
| 2016 Q2 | 16 Million USD | 28.31% |
| 2016 Q4 | 21.91 Million USD | 23.5% |
| 2016 Q3 | 17.74 Million USD | 10.86% |
| 2016 FY | 68.13 Million USD | 25.52% |
| 2015 Q4 | 17.89 Million USD | 32.66% |
| 2015 FY | 54.28 Million USD | 25.15% |
| 2015 Q3 | 13.49 Million USD | 4.78% |
| 2015 Q2 | 12.87 Million USD | 28.52% |
| 2015 Q1 | 10.01 Million USD | -27.5% |
| 2014 Q1 | 8.88 Million USD | -31.84% |
| 2014 Q2 | 9.87 Million USD | 11.14% |
| 2014 Q3 | 10.79 Million USD | 9.26% |
| 2014 Q4 | 13.82 Million USD | 28.07% |
| 2014 FY | 43.37 Million USD | 3.56% |
| 2013 Q1 | 8.55 Million USD | -32.9% |
| 2013 FY | 41.88 Million USD | 0.82% |
| 2013 Q4 | 13.03 Million USD | 42.06% |
| 2013 Q3 | 9.17 Million USD | -17.46% |
| 2013 Q2 | 11.11 Million USD | 30.04% |
| 2012 Q3 | 10.59 Million USD | 2.72% |
| 2012 FY | 41.54 Million USD | 21.07% |
| 2012 Q1 | 7.88 Million USD | -28.58% |
| 2012 Q2 | 10.31 Million USD | 30.89% |
| 2012 Q4 | 12.74 Million USD | 20.24% |
| 2011 Q3 | 8.46 Million USD | 0.49% |
| 2011 Q2 | 8.41 Million USD | 31.61% |
| 2011 Q1 | 6.39 Million USD | -28.79% |
| 2011 FY | 34.31 Million USD | 13.56% |
| 2011 Q4 | 11.03 Million USD | 30.45% |
| 2010 Q4 | 8.98 Million USD | 39.68% |
| 2010 FY | 30.21 Million USD | -5.35% |
| 2010 Q1 | 7.92 Million USD | -17.78% |
| 2010 Q2 | 6.88 Million USD | -13.11% |
| 2010 Q3 | 6.43 Million USD | -6.55% |
| 2009 Q1 | 8.49 Million USD | -21.73% |
| 2009 Q2 | 6.53 Million USD | -23.06% |
| 2009 Q4 | 9.63 Million USD | 32.67% |
| 2009 Q3 | 7.26 Million USD | 11.11% |
| 2009 FY | 31.92 Million USD | -37.43% |
| 2008 Q1 | 13.39 Million USD | -20.0% |
| 2008 Q3 | 11.28 Million USD | -27.1% |
| 2008 Q4 | 10.85 Million USD | -3.85% |
| 2008 FY | 51.02 Million USD | -23.53% |
| 2008 Q2 | 15.48 Million USD | 15.55% |
| 2007 Q3 | 18.53 Million USD | 16.12% |
| 2007 Q4 | 16.74 Million USD | -9.64% |
| 2007 FY | 66.72 Million USD | -5.8% |
| 2007 Q1 | 15.47 Million USD | -30.07% |
| 2007 Q2 | 15.96 Million USD | 3.15% |
| 2006 Q1 | 14.94 Million USD | -16.05% |
| 2006 Q4 | 22.13 Million USD | 29.22% |
| 2006 Q3 | 17.12 Million USD | 3.01% |
| 2006 Q2 | 16.62 Million USD | 11.25% |
| 2006 FY | 70.83 Million USD | 26.88% |
| 2005 FY | 55.82 Million USD | 47.1% |
| 2005 Q4 | 17.8 Million USD | 25.34% |
| 2005 Q3 | 14.2 Million USD | 11.96% |
| 2005 Q2 | 12.68 Million USD | 13.96% |
| 2005 Q1 | 11.13 Million USD | -6.11% |
| 2004 FY | 37.95 Million USD | 41.77% |
| 2004 Q3 | 9.29 Million USD | 4.85% |
| 2004 Q1 | 7.93 Million USD | -9.21% |
| 2004 Q2 | 8.86 Million USD | 11.75% |
| 2004 Q4 | 11.85 Million USD | 27.57% |
| 2003 Q4 | 8.73 Million USD | 17.89% |
| 2003 Q2 | 6.25 Million USD | 0.0% |
| 2003 FY | 26.77 Million USD | 46.0% |
| 2003 Q3 | 7.41 Million USD | 18.44% |
| 2002 FY | 18.33 Million USD | 48.03% |
| 2001 FY | 12.38 Million USD | 100.89% |
| 2000 FY | 6.16 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -1527.216% |
| BrainsWay Ltd. | 23.09 Million USD | -79.698% |
| Cerus Corporation | 86.4 Million USD | 51.975% |
| Envoy Medical, Inc. | -473 Thousand USD | 8872.516% |
| electroCore, Inc. | 13.22 Million USD | -213.731% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -67922.951% |
| IceCure Medical Ltd | 1.3 Million USD | -3091.846% |
| Inogen, Inc. | 126.69 Million USD | 67.25% |
| OrthoPediatrics Corp. | 111.25 Million USD | 62.703% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 785.851% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 87758.442% |
| MaxCyte, Inc. | 36.54 Million USD | -13.539% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -8989.256% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -48682.036% |
| Orthofix Medical Inc. | 486.27 Million USD | 91.467% |
| PAVmed Inc | -3.96 Million USD | 1145.716% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 856.5% |
| RxSight, Inc. | 53.76 Million USD | 22.823% |
| Sight Sciences, Inc. | 69.17 Million USD | 40.016% |
| SI-BONE, Inc. | 109.42 Million USD | 62.078% |
| TELA Bio, Inc. | 40.11 Million USD | -3.445% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 72.69% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -401.681% |
| Acutus Medical, Inc. | -3.13 Million USD | 1422.729% |
| Talis Biomedical Corporation | 371 Thousand USD | -11084.367% |
| Spectral AI, Inc. | 7.88 Million USD | -426.574% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 729.46% |
| CVRx, Inc. | 33.03 Million USD | -25.591% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -5510.891% |
| Bioventus Inc. | 328.19 Million USD | 87.357% |
| Venus Concept Inc. | 52.16 Million USD | 20.459% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -160.87% |
| LivaNova PLC | 771.25 Million USD | 94.62% |
| 908 Devices Inc. | 25.32 Million USD | -63.865% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 86.624% |
| Nemaura Medical Inc. | -1.47 Million USD | 2910.5% |
| NeuroPace, Inc. | 48.12 Million USD | 13.773% |
| LENSAR, Inc. | 21.1 Million USD | -96.589% |
| Apyx Medical Corporation | 14.12 Million USD | -193.825% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -124.766% |
| BioSig Technologies, Inc. | 18 Thousand USD | -230422.222% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 59.749% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -204.789% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 95.329% |
| Axonics, Inc. | 274.55 Million USD | 84.887% |
| Outset Medical, Inc. | 29 Million USD | -43.083% |
| IRIDEX Corporation | 21.8 Million USD | -90.278% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 41.598% |
| IRadimed Corporation | 50.15 Million USD | 17.274% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -14357.84% |
| INVO Bioscience, Inc. | 1.08 Million USD | -3720.325% |
| Telesis Bio, Inc. | 16.95 Million USD | -144.802% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 63.209% |
| Varex Imaging Corporation | 256.9 Million USD | 83.848% |
| Quipt Home Medical Corp. | 163.84 Million USD | 74.675% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 10320.197% |
| Pulmonx Corporation | 50.75 Million USD | 18.242% |
| Dynatronics Corporation | 7.63 Million USD | -443.472% |
| Modular Medical, Inc. | -768 Thousand USD | 5502.865% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -647.909% |
| Semler Scientific, Inc. | 61.2 Million USD | 32.199% |
| InMode Ltd. | 411.34 Million USD | 89.912% |
| Bruker Corporation | 1.51 Billion USD | 97.264% |
| Cytosorbents Corporation | 22.39 Million USD | -85.307% |
| DexCom, Inc. | 2.28 Billion USD | 98.187% |
| Align Technology, Inc. | 2.71 Billion USD | 98.474% |
| Viveve Medical, Inc. | 620 Thousand USD | -6592.581% |
| ZimVie Inc. | 290.38 Million USD | 85.711% |
| Movano Inc. | -158 Thousand USD | 26362.025% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 62.08% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -48682.036% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 88.715% |
| Profound Medical Corp. | 4.51 Million USD | -819.225% |
| Insulet Corporation | 1.15 Billion USD | 96.423% |
| enVVeno Medical Corporation | -546 Thousand USD | 7699.634% |
| Surmodics, Inc. | 93.05 Million USD | 55.408% |
| iCAD, Inc. | 14.53 Million USD | -185.457% |
| Nuwellis, Inc. | 4.98 Million USD | -732.711% |
| Biotricity, Inc. | 8.35 Million USD | -396.561% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 87.494% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 11656.382% |
| InspireMD, Inc. | 1.8 Million USD | -2196.292% |
| PAVmed Inc. | -3.96 Million USD | 1145.716% |
| BIOLASE, Inc. | 16.72 Million USD | -148.11% |
| Beyond Air, Inc. | -1.3 Million USD | 3274.751% |
| FONAR Corporation | 45.14 Million USD | 8.077% |
| AxoGen, Inc. | 127.87 Million USD | 67.551% |
| Vivani Medical, Inc. | -357 Thousand USD | 11722.969% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 78.736% |
| Inari Medical, Inc. | 434.56 Million USD | 90.452% |
| UFP Technologies, Inc. | 112.22 Million USD | 63.026% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -331348.199% |
| Tenon Medical, Inc. | 1.24 Million USD | -3243.594% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 51327.16% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -1479.467% |
| AdaptHealth Corp. | 479.56 Million USD | 91.348% |
| Sintx Technologies, Inc. | 1.84 Million USD | -2151.438% |
| NanoVibronix, Inc. | 1.53 Million USD | -2599.675% |
| Quanterix Corporation | 70.64 Million USD | 41.265% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 10320.197% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -195.121% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 21.383% |
| TransMedics Group, Inc. | 154.09 Million USD | 73.072% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -831.821% |
| NeuroMetrix, Inc. | 3.94 Million USD | -951.169% |
| Hyperfine, Inc. | 4.75 Million USD | -772.272% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 61.212% |
| Biomerica, Inc. | 611 Thousand USD | -6691.162% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 0.464% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 5413.238% |
| Silk Road Medical, Inc | 127.08 Million USD | 67.35% |